Morgan Stanley Alpha Tau Medical Ltd. Transaction History

Morgan Stanley

$1.59 Trillion
Q3 2025

A detailed history of Morgan Stanley transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Morgan Stanley holds 50,008 shares of DRTS stock, worth $185,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,008

Previous 38,550 29.72%

Holding current value

$185,529

Previous $120,000 87.5%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$2.9 - $4.51 $33,228 - $51,675	11,458 Added 29.72%	50,008 $225,000
Q2 2025 Aug 15, 2025	SELL	$2.45 - $3.26 $11,737 - $15,618	-4,791 Reduced 11.05%	38,550 $120,000
Q1 2025 May 15, 2025	BUY	$2.51 - $4.2 $978 - $1,638	390 Added 0.91%	43,341 $108,000
Q4 2024 Feb 14, 2025	SELL	$2.17 - $3.18 $846 - $1,240	-390 Reduced 0.9%	42,951 $133,000
Q2 2024 May 14, 2025	BUY	$2.05 - $2.9 $799 - $1,131	390 Added 0.91%	43,341 $109,000

Q2 2024 Oct 17, 2024	SELL	$2.05 - $2.9 $543,744 - $769,198	-265,241 Reduced 85.95%	43,341 $109,000
Q2 2024 Aug 14, 2024	SELL	$2.05 - $2.9 $543,744 - $769,198	-265,241 Reduced 85.95%	43,341 $109,000
Q1 2024 Oct 17, 2024	BUY	$2.84 - $3.35 $753,284 - $888,557	265,241 Added 611.99%	308,582 $910,000
Q1 2024 Aug 16, 2024	BUY	$2.84 - $3.35 $9,656 - $11,390	3,400 Added 1.11%	308,582 $910,000
Q1 2024 May 15, 2024	BUY	$2.84 - $3.35 $9,656 - $11,390	3,400 Added 1.11%	308,582 $910,000
Q4 2023 Aug 16, 2024	BUY	$2.75 - $3.89 $720,062 - $1.02 Million	261,841 Added 604.14%	305,182 $918,000
Q4 2023 Feb 13, 2024	BUY	$2.75 - $3.89 $728,417 - $1.03 Million	264,879 Added 657.22%	305,182 $918,000
Q2 2023 Aug 14, 2023	BUY	$2.76 - $4.72 $59,891 - $102,424	21,700 Added 116.65%	40,303 $176,000
Q4 2022 Feb 14, 2023	BUY	$3.05 - $5.49 $21,411 - $38,539	7,020 Added 60.61%	18,603 $59,000
Q3 2022 Nov 14, 2022	SELL	$0.65 - $11.0 $4,499 - $76,142	-6,922 Reduced 37.41%	11,583 $67,000
Q2 2022 Oct 27, 2022	BUY	$5.19 - $12.67 $60,489 - $147,668	11,655 Added 170.15%	18,505 $167,000
Q2 2022 Aug 15, 2022	BUY	$5.19 - $12.67 $60,489 - $147,668	11,655 Added 170.15%	18,505 $167,000
Q1 2022 Oct 27, 2022	SELL	$8.92 - $15.3 $103,962 - $178,321	-11,655 Reduced 62.98%	6,850 $81,000
Q1 2022 May 13, 2022	BUY	$8.92 - $15.3 $61,102 - $104,805	6,850 New	6,850 $81,000

Others Institutions Holding DRTS

# of Institutions

Shares Held

2.25M

Call Options Held

Put Options Held

View Full List

About Alpha Tau Medical Ltd.

Ticker DRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,011,296
Market Cap $256M
Description
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...

More about DRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account